News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Evotec AG (EVTG.F) Receives Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim Corporation



9/30/2013 9:04:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HAMBURG, Germany, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone in September triggering revenues of € 2.0 m to Evotec. The milestone was for the transition of an oncology molecule into Phase I clinical trials.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES